Top compounds associated with response to ANKRD10


Feature Type Standardized
Nominal ANOVA
mRNA PFI-1 GDSC1000 pan-cancer AAC -0.092 0.006
mRNA piperlongumine GDSC1000 pan-cancer AAC -0.091 0.006
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.087 0.006
mRNA BMS-754807 GDSC1000 pan-cancer AAC 0.092 0.007
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC -0.083 0.007
mRNA AT-7519 GDSC1000 pan-cancer AAC 0.08 0.007
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.008
mRNA methylstat CTRPv2 pan-cancer AAC 0.11 0.009
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.009
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.009
Download CSV